Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 6
2017 3
2018 1
2023 1
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.
Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, Peyrin-Biroulet L, D'Haens G, Hisamatsu T, Siegmund B, Wu K, Boland BS, Melmed GY, Armuzzi A, Levine P, Kalabic J, Chen S, Cheng L, Shu L, Duan WR, Pivorunas V, Sanchez Gonzalez Y, D'Cunha R, Neimark E, Wallace K, Atreya R, Ferrante M, Loftus EV Jr; INSPIRE and COMMAND Study Group. Louis E, et al. JAMA. 2024 Sep 17;332(11):881-897. doi: 10.1001/jama.2024.12414. JAMA. 2024. PMID: 39037800 Clinical Trial.
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial.
Danese S, Panaccione R, Feagan BG, Afzali A, Rubin DT, Sands BE, Reinisch W, Panés J, Sahoo A, Terry NA, Chan D, Han C, Frustaci ME, Yang Z, Sandborn WJ, Hisamatsu T, Andrews JM, D'Haens GR; GALAXI-1 Study Group. Danese S, et al. Lancet Gastroenterol Hepatol. 2024 Feb;9(2):133-146. doi: 10.1016/S2468-1253(23)00318-7. Epub 2023 Dec 14. Lancet Gastroenterol Hepatol. 2024. PMID: 38104569 Clinical Trial.
Precursors of pancreatic cancer.
Frič P, Škrha J, Šedo A, Bušek P, Laclav M, Bunganič B, Zavoral M. Frič P, et al. Among authors: laclav m. Eur J Gastroenterol Hepatol. 2017 Mar;29(3):e13-e18. doi: 10.1097/MEG.0000000000000810. Eur J Gastroenterol Hepatol. 2017. PMID: 28009716 Review.
Early detection of sporadic pancreatic cancer: time for change.
Frič P, Šedo A, Škrha J, Bušek P, Laclav M, Škrha P, Zavoral M. Frič P, et al. Among authors: laclav m. Eur J Gastroenterol Hepatol. 2017 Aug;29(8):885-891. doi: 10.1097/MEG.0000000000000904. Eur J Gastroenterol Hepatol. 2017. PMID: 28471824 Review.
[Early detection of sporadic pancreatic cancer].
Frič P, Šedo A, Škrha J, Zima T, Bušek P, Škrha P, Kmochová K, Laclav M, Bunganič B, Zavoral M. Frič P, et al. Among authors: laclav m. Cas Lek Cesk. 2016;155(1):44-7. Cas Lek Cesk. 2016. PMID: 26898791 Review. Czech.
Accuracy of EUS and CEH EUS for the diagnosis of pancreatic tumours.
Bunganič B, Laclav M, Dvořáková T, Bradáč O, Traboulsi E, Suchánek Š, Frič P, Zavoral M. Bunganič B, et al. Among authors: laclav m. Scand J Gastroenterol. 2018 Oct-Nov;53(10-11):1411-1417. doi: 10.1080/00365521.2018.1524023. Epub 2018 Nov 5. Scand J Gastroenterol. 2018. PMID: 30394143
13 results